NCT04035538

A Clinical Study to Compare the Safety and Pharmacokinetics of CKD-320 and D012

A Randomized, Open-label, Single-dose, Replicate-crossover Study to Compare the Safety and Pharmacokinetics of CKD-320 and D012 in Healthy Subjects

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 42 (estimated)
• Sponsor: Chong Kun Dang Pharmaceutical · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Accepted

Summary

A clinical study to compare the safety and pharmacokinetics of CKD-320 and D012

Detailed description

A randomized, open-label, single-dose, replicate-crossover study to compare the safety and pharmacokinetics of CKD-320 and D012 in healthy subjects

Conditions

• Hypertension

Interventions

Type	Name	Description
DRUG	CKD-320, D012	R: D012 1tablet, QD, PO T: CKD-320 2tablets, QD, PO

Timeline

• Start date: 2019-08-01
• Primary completion: 2019-11-01
• Completion: 2019-12-01
• First posted: 2019-07-29
• Last updated: 2019-07-29